Clinical Trial Update: Buphenyl Therapy for Byler's Disease

View source ↗

Summary

Clinical trial update indicates that Buphenyl therapy for progressive familial intrahepatic cholestasis (Byler disease) is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Familial Intrahepatic Cholestasis

Drugs mentioned

• BUPHENYL (Sodium phenylbutyrate)

Snippet

Sponsor: University of Pittsburgh | Conditions: Byler Disease | Status: NO_LONGER_AVAILABLE